Expression of a Truncated Keratin 5 May Contribute to Severe Palmar–Plantar Hyperkeratosis in Epidermolysis Bullosa Simplex Patients  by Livingston, Robert J. et al.
Expression of a Truncated Keratin 5 May Contribute to
Severe Palmar±Plantar Hyperkeratosis in Epidermolysis
Bullosa Simplex Patients
Robert J. Livingston,* Virginia P. Sybert,² Lynne T. Smith,² Beverly A. Dale,²§¶ Richard B. Presland,²§ and
Karen Stephens*²**
Departments of *Pathology, ²Medicine, §Oral Biology, ¶Periodontics and Biochemistry, and **Department of Laboratory Medicine, University of
Washington, Seattle, Washington, U.S.A.
Epidermolysis bullosa simplex are dominant
disorders of skin fragility characterized by intraepi-
dermal blistering upon mild mechanical trauma.
Skin fragility is caused by expression of either an
abnormal keratin 5 or an abnormal keratin 14
protein, which compromises the structure and func-
tion of the keratin cytoskeleton of basal cells. We
report an epidermolysis bullosa simplex patient with
a novel single base substitution (A®T1414) that
changes the lysine residue at amino acid 472 to a
non-sense codon (K472X). This change predicts the
synthesis of a truncated keratin 5, missing 119 amino
acids, including the entire tail domain and the highly
conserved KLLEGE motif at the carboxy terminus of
the 2B domain of the central rod. Expression of an
altered keratin 5, of predicted mass and pI for the
product of the K472X allele, was documented by
one- and two-dimensional western blots of protein
extracts from patient skin. Ultrastructural analysis of
the patient's nonhyperkeratotic skin was remarkable
for basal keratinocytes with dense and irregular kera-
tin ®laments proximal to the basement membrane.
Keratinocytes, transfected with a cDNA carrying the
A®T1414 non-sense mutation, overexpressed a trun-
cated keratin 5, and showed a disorganized and
collapsed keratin ®lament cytoskeleton. This is the
second epidermolysis bullosa simplex patient
reported with a premature termination mutation in
the KLLEGE motif. The remarkable occurrence of
severe palmar±plantar hyperkeratosis in both patients
suggests that the keratin 5 tail domain may have
unrecognized, but important, normal functions in
palmar±plantar tissues. Key words:keratin ®laments/
KLLEGE motif/KRTS. J Invest Dermatol 116:970±974,
2001
E
pidermolysis bullosa simplex (EBS) describes a group of
inherited disorders of skin fragility characterized by
intraepidermal blistering upon mild mechanical trauma
Sybert, 1997; Horn and Tidman, 2000). The autosomal
dominant forms of EBS have been divided into three
major subtypes based on the extent and severity of blistering (Fine
et al, 2000). The mildest is Weber±Cockayne with blisters limited to
palms and soles, whereas the Koebner subtype shows generalized
blistering. The most severe subtype, Dowling±Meara is character-
ized by generalized blistering in a herpetiform pattern and keratin
®lament (KIF) structural abnormalities in basal cells and can result in
neonatal death. Because these subtypes are not clinically distinct and
they all result from mutations in the same basal cell-speci®c keratins,
it is appropriate to consider disease severity of EBS as a continuum.
The cause of EBS disorders is a mutation in either the KRT5 or
KRT14 gene, which encode keratins K5 and K14, respectively.
Normally, these two keratins form obligate heterodimers that
assemble into the KIF of the basal cells of the epidermis. KRT5 and
KRT14 mutations causing dominant EBS are almost exclusively
amino acid substitutions (Coulombe et al, 1991a; Pulkkinen and
Uitto, 1999; Stephens et al, 1993, 1997). Exceptions include an in-
frame deletion (Rugg et al, 1999) and a non-sense mutation
(Muller et al, 1999). Each of these mutations predicts the synthesis
of an abnormal keratin protein. Keratins are comprised of a highly
conserved central a-helical rod domain ¯anked by loosely
conserved head and tail domains. Mis-sense mutations at either
end of the central rod domain are typically the most disruptive to
KIF organization and cause more severe clinical disease (Coulombe
et al, 1991b; Letai et al, 1993). Ultrastructural and mutational
analyses, in vitro assembly, and transgenic mice studies all indicate
that abnormal K5 or K14 molecules behave in a dominant negative
fashion to disrupt the KIF cytoskeleton (Coulombe et al, 1991a;
Vassar et al, 1991; Steinert et al, 1993b; Irvine and McLean, 1999).
We report an exceptional case of a patient with EBS and unusually
severe palmar±plantar hyperkeratosis with a non-sense mutation in
the highly conserved KLLEGE motif at the end of the central rod.
Evidence in support of this mutation underlying both EBS and
palmar±plantar hyperkeratosis are presented.
MATERIALS AND METHODS
Histology and ultrastructural analysis Nonhyperkeratotic skin was
gently rubbed and a 2 mm punch biopsy was taken from the arm. The
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tissue was placed in 3% glutaraldehyde and processed into Epon as
previously described (Smith et al, 1992). Thin sections were stained with
uranyl acetate and lead citrate and viewed using a Philips 420 STEM
operated at 60 kV.
Mutational analysis Exon-speci®c ampli®cation of the KRT5 and
KRT14 genes was performed using primers described previously (Chen
et al, 1995; Stephens et al, 1997) and products were sequenced directly
(Sequenase, United States Biochemical). The A®T1414 mutation in
exon 7 was ampli®ed with primers G1 and G2 (Stephens et al, 1997). In
addition, the KRT5 exon 7 fragment of both alleles of the patient were
cloned in the pCRII T/A vector (Invitrogen, Carlsbad, CA) and
sequenced.
Western blots Epidermal Tris/urea extracts were prepared from a
2 mm punch biopsy of epidermis from the patient or an age-matched
control individual, or from human foreskin as described previously
(Sybert et al, 1985; Presland et al, 1997). For one-dimensional
electrophoresis, proteins were separated using 7.5±12% gradient sodium
dodecyl sulfate±polyacrylamide gel electrophoresis gel and electroblotted
on to nitrocellulose membrane for 12 h, 100 mA, 4°C. One-dimensional
western blots were reacted with the monoclonal antibody AE3
(Woodcock-Mitchell et al, 1982) and immunoreactive proteins were
visualized with the avidin±biotin method using 4-chloro-1-naphthol
(Towbin et al, 1979). Proteins for two-dimensional analysis were
separated by charge in the ®rst dimension using the nonequilibrium
gradient system (NEpHGE; O'Farrell et al, 1977; Harding and Scott,
1983) and by molecular weight in the second dimension through a 7±
12% gradient sodium dodecyl sulfate±polyacrylamide gel electrophoresis
gel (Jule Biotechnologies, Inc., New Haven, CT). Samples were
electroblotted as above and probed with either a polyclonal pan-keratin
antibody (BioGenex, San Ramon, CA) or a monoclonal anti-cytokeratin
no. 5/6 (Roche Molecular, Indianapolis, IN). Theoretical pI values were
calculated with the EXPASY program (http://ca.expasy.org/tools/
pi_tool.html).
Transient transfections The coding region of KRT5 was cloned in
the expression vector pcDNA3 (Invitrogen), which was modi®ed to
contain an N-terminal FLAG sequence (Dale et al, 1997). The clone of
the normal KRT5 allele, termed pFLAGK5.0, was constructed by the
assembly of fragments from several plasmids (inquire for details, RJL)
resulting in an in-frame fusion of a 5¢ FLAG tag and a KRT5 cDNA
fragment from the initiating AUG to the XbaI site, which is located 114
nucleotides downstream from the termination codon (XbaI site at 2271,
GenBank accession M21389). The mutant KRT5 allele was cloned by
excising the BsmI±NgoMI fragment containing the A1414 site from
pFLAGK5.0 and replacing it with a fragment carrying the A®T1414
mutation. The mutated fragment was synthesized by amplifying a
plasmid carrying the K5 coding sequence with the anti-sense primer K5-
T1805A (5¢AGTCTGCATTCCTCGCCCTCCAGCAGCTAGCG)
containing the 1 base mutation (underlined) and a native BsmI site, and
the sense primer K5-1503 (5¢CAGCTGGCCGGCATGGCGAT),
containing a native NgoMI site. The mutation created a unique NheI
site, which was used to select a positive clone designated pFLAGK5.1.
All constructs were con®rmed by sequencing; 2.5 mg of either
pFLAGK5.0, pFLAGK5.1 or pSV_gal (Promega, Madison, WI) was
transfected with lipofectamine (Life Technologies, Rockville, MD) into
COS or rat epidermal keratinocyte cells (Dale et al, 1997). After 72 h,
cells were harvested by scraping, washed in cold phosphate-buffered
saline, extracted with 8 M urea and 0.25 M Tris±HCl pH 7.6, and
proteins were analyzed by sodium dodecyl sulfate±polyacrylamide gel
electrophoresis and immunoblotting as described above. Western blots
were reacted with either the anti-cytokeratin 5/6 or the anti-FLAG
monoclonal antibody (Eastman Kodak) antibody and ABC conjugated
alkaline phosphatase (Vector Labs, Burlingame, CA). For double label
immuno¯uorescence, transiently transfected cells were washed in
phosphate-buffered saline, ®xed for 10 min at ±20°C in methanol/
acetone (1:3), washed in phosphate-buffered saline, and reacted with
anti-FLAG primary monoclonal antibody M2 (Eastman Kodak,
Rochester, NY) followed by horse anti-mouse IgG and streptavidin
Texas red (Vector Labs). Keratins were labeled with AE3 followed by
biotinylated goat anti-rabbit antibody and Texas red-conjugated
strepavidin. Cells were cover-slipped using Vectashield (Vector Labs) and
visualized by epi¯uorescense using an Olympus BH-2 microscope.
RESULTS
Case report The patient is a male who presented at 3±4 d of age
with widespread blistering. He required multiple hospitalizations for
Figure 1. Palmar hyperkeratosis and epidermal structure of the
EBS patient. (A) The patient's hands show mild contractures of distal
phalanges with loss of some pulp on tips, thinned skin, and signs of
chronic injury. The palmar view shows marked hyperkeratosis and mild
contractures of ®ngers. (B) Light microscopy (inset a) showed focal areas
of basal cytolysis. (b) Electron microscopy showed a generally sparse KIF
with an accumulation of dense and irregularly packed KIF just super®cial
to the basement membrane (arrows).
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blistering during childhood. Painful hyperkeratosis of the palms and
soles developed in his teen years, whereas blistering improved
somewhat with age. During his employment as a horse trainer, he
would also blister on the buttocks and thighs. At age 57, he continues
to get occasional blisters in the mouth and cutaneous blisters with
increased heat and/or activity. His skin examination is striking for
marked palmar±plantar hyperkeratosis with underlying erythema in
a glove and moccasin distribution with limited range of motion of his
®ngers (Fig 1A). There are multiple blisters on his extremities, mild
hyperpigmentation, and no scarring. There are no signi®cant nail
changes. The family history is negative; he is the only affected
individual among nine siblings born to unaffected parents and he has
two unaffected daughters. He was the youngest member of his
sibship, both parents in their forties at the time of his birth.
Epidermal structure Light microscopy of the patient's skin
revealed focal areas of lysis of basal keratinocytes (Fig 1B). This
skin from the upper arm was of normal thickness, with no
hyperkeratosis or parakeratosis. Ultrastructural analysis was notable
for the signi®cant variability in the distribution of KIF. Whereas
KIF density and organization in basal cells appeared normal in some
areas, other areas showed basal cells with KIF that were densely and
irregularly organized proximal to the basement membrane
(Fig 1B). Skewed KIF distribution, rarely noted in normal skin
and occasionally observed in skin from individuals with EBS, was a
prominent feature in the tissue of this patient. An increase in
intercellular vacuoles was also detected. The structure and
organization of keratin ®laments in the other layers of the
epidermis appeared normal. The dense whorls or circumscribed
clumps of basal KIF, which are pathognomonic for the Dowling±
Meara subtype of EBS, were not present. Together these features,
along with the patient's clinical history, are consistent with a
diagnosis of generalized EBS (Koebner subtype).
KRT5 mutation that truncates the protein The clinical
diagnosis suggested a primary defect in either the KRT5 or
KRT14 gene. Direct sequencing of exon-speci®c amplicons of
these genes revealed a heterozygous A®T substitution in the
KRT5 gene at base 1414 (A®T1414; Fig 2A), which is nucleotide
position 88 in the 2B rod domain. This mutation changes the AAG
lysine codon at amino acid 472 to a TAG premature termination
codon. K472 is in the highly conserved KLLEGE motif at the end
of the K5 rod domain (Fig 2B). The mutant allele predicts the
synthesis of a K5 protein lacking the carboxy terminal 119 amino
acids with a lesser mass of 50 kDa and a theoretical pI of 6.43.
To determine if the truncated K5 protein was detectable in the
patient's skin, one- and two-dimensional western blots analyses
were performed. A novel protein doublet of about 50 kDa was
detected in the patient's epidermal extract by AE3, a keratin type
II-speci®c antibody (Fig 3A, arrow). Two-dimensional western
analyses with a K5/K6 antibody was performed to determine if
either of these novel proteins represented the predicted truncated
K5. Compared with that of an age-matched control skin sample
(Fig 3B2), the patient's extract showed one novel keratin protein
with a decreased mass and more neutral pI (Fig 3B3). Although the
antibody can recognize both K5 and K6, this novel protein cannot
be K6 based on both mass and charge (Moll et al, 1982). The masses
of K5, K6, and K5-K472X are 58, 56, and 50 kDa, respectively.
The theoretical pI values of K5, K6, and K5-K472X are 8.1, 8.1,
and 6.43 (see Materials and Methods). Therefore, the novel band,
with a more acidic pI and lower molecular weight than K6,
represents the truncated K5-K472X. The basis for the novel
doublet observed in the one-dimensional gel is unclear, but may
represent charge variation due to phosphorylation.
The truncated K5 protein disrupts KIF organization
Transient transfections were performed to test whether the
truncated K5 protein had a dominant negative effect on the KIF
cytoskeleton. A full-length KRT5 cDNA, or a full-length KRT5
cDNA containing the A®T1414 mutation, was transiently
expressed in rat epidermal keratinocyte and COS cells. Western
blot analyses demonstrated that each transgene expressed the
expected normal 58 kDa or mutant 50 kDa protein (data not
Figure 3. Expression of a truncated K5 in the patient's epidermis.
(A) Lanes 1±3 are stained proteins and lanes 4±6 are western blotted
proteins reacted with AE3, a keratin type II-speci®c antibody. Lanes 1
and 2 (more protein loaded) patient skin extracts; lane 3, foreskin extract;
lane 4 (more protein loaded), lane 5, patient skin extracts; lane 6, foreskin
extracts. (B) Two-dimensional electrophoresis of epidermal extracts from
an age-matched control individual stained (lanes 1 and 2) and nonlesional
skin of the patient (lane 3). Proteins were stained (lane 1) or reacted with
an anti-K5/K6 antibody (lanes 2 and 3). Arrows indicate novel keratin
detected in the patient's epidermis. As expected, AE3 also reacted with
the K1 (68.5 kDa) and the full-length K5 (58 kDa) from the patient's
normal allele.
Figure 2. KRT5 non-sense mutation in the conserved KLLEGE
motif. (A) Sequence of KRT5 exon 7 of the patient's normal and
mutant alleles. This sequence from cloned amplicons was con®rmed by
direct sequencing of genomic polymerase chain reaction products and by
restriction with NheI, a novel endonuclease site created by the
A®T1414 substitution. A screen of 58 normal KRT5 alleles for the
A®T1414 mutation by NheI restriction was negative. These data
support the pathogenicity of this sequence change. Nucleotides
numbered with the A of the initiating AUG codon as position 1. Within
the K5 2B domain, this mutation is at nucleotide position 88. (B)
Schematic of the K5 domain structure showing the head and tail
domains and the highly conserved KLLEGE motif at the carboxy
terminus of the 2B domain of the central rod. Note that in K14, and
other type I keratins, an arginine replaces the lysine resulting in a
conserved RLLEGE domain.
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shown). Immuno¯uorescence revealed that whereas expression of
the normal full-length K5 cDNA showed no detectable affect on
the cytoskeleton, expression of the A®T1414 full-length cDNA
disrupted the KIF resulting in a perinuclear collapse of the
cytoskeleton (Fig 4).
DISCUSSION
The association of EBS disease with unusually severe palmar±
plantar hyperkeratosis in this patient suggested that both clinical
features might be caused by a single keratin mutation. The
identi®cation of a novel KRT5 non-sense mutation permitted
analysis of its effects in vivo and in vitro. The K472X premature stop
codon predicts translation of a truncated K5 protein. Because
mRNA containing premature stop codons are often degraded
rapidly, a phenomenon called non-sense-mediated decay (reviewed
in Culbertson, 1999; Frischmeyer and Dietz, 1999), it was
important to con®rm that the K472X allele actually expressed a
truncated K5 in the patient's skin. Because dominant forms of EBS
are caused by the disruptive presence of an abnormal keratin
protein, if a truncated K5 was undetectable, then the K472X allele
would be an unlikely cause of the patient's EBS disease. Analyses of
rare families with null K14 mutations clearly demonstrated that
individuals heterozygous for a null keratin mutation are unaffected
and have normal basal KIF structure (Chan et al, 1994; Rugg et al,
1994; Jonkman et al, 1996; Corden et al, 1998).
We found that the truncated K5 was expressed and highly likely
to be incorporated into the keratin cytoskeleton of the patient's
basal cells. Two-dimensional western blots with a K5/K6-speci®c
antibody detected two K5 proteins. The mass and pI of each
protein was consistent with a normal K5 and a K472X truncated
K5 (Fig 3A). As expected, K6, generally associated with
hyperproliferation, was not detected in this biopsy of nonhyper-
keratotic tissue from the patient. Transfected keratinocytes express-
ing an engineered A®T1414 mutated K5 protein had a disrupted
keratin network demonstrating that this truncated protein can form
heterodimers with K14 and incorporate into an existing KIF
cytoskeleton (Fig 4). The disrupted cytoskeleton was indistin-
guishable from that observed in cells expressing KRT5 or KRT14
alleles with mis-sense mutations (Coulombe et al, 1991a). Because
keratin monomers are highly unstable and immediately form coil-
coiled obligate heterodimers with their respective keratin partners,
the truncated K5 in the patient's epidermis was likely to be
incorporated into the cytoskeleton. Furthermore, tail-less keratins
can incorporate into an existing KIF network and participate in de
novo ®lament assembly with a normal full-length keratin partner (Lu
and Lane, 1990; Bader et al, 1991; Lu et al, 1993). Tail domain
interactions contribute to ®lament elongation (Lu and Lane, 1990;
Wilson et al, 1992) and the H2 subdomain of the tail plays a part in
the registration of neighboring molecules (Steinert and Parry,
1993).
Mis-sense mutations in patients with EBS, in vitro studies, and the
high degree of conservation underscore the importance of the
KLLEGE motif at the carboxy terminal end of the a-helical central
rod domain (Fig 3) (Magin et al, 1987; Hatzfeld and Weber, 1991).
Cross-linking experiments demonstrated that KLLEGE is an
important region of molecular overlap of keratins (Steinert et al,
1993a) and assembly assays indicated that this motif is crucial for
controlling ®lament width (Herrmann et al, 2000). Single base
substitution mutations at both glutamate residues of the KLLEGE
domain have been reported in individuals/pedigrees with EBS±
Dowling±Meara. These mutations, E475G and E477K, caused
extensive clumping of basal KIF (Lane et al, 1992; Stephens et al,
1997). Therefore, the deletion of both the KLLEGE motif and tail
of K5 in our patient, whose basal KIF showed mild disorganization,
but no clumping (Fig 1B), is less disruptive to the cytoskeleton and
causes milder disease than amino acid substitutions in the KLLEGE
motif.
Several in vitro studies have documented the deleterious effects of
truncated keratins that lack both the KLLEGE motif and the tail
domain. Transfection of a K14 missing the RLLEGE motif (see
Fig 3 legend) and tail caused marked disruption of the K8/K18
KIF network (Albers and Fuchs, 1987). In vitro assembly of K5 or
K14 lacking the R/KLLEGE motif and tail, with their normal
length keratin partners demonstrated the role of these domains in
proper lateral alignment of proto®brils (Wilson et al, 1992). These
data are supported by similar experiments with vimentin and
desmin intermediate ®laments (Herrmann et al, 2000).
Can the patient's truncated K5 account for both the blistering
phenotype of EBS and the palmar±plantar hyperkeratosis? Clearly,
our observations and previous reports on KLLEGE and tail
Figure 4. Expression of truncated K5 disrupted the KIF network.
Transient transfectants of rat epidermal keratinocyte cells with full-length
KRT5 cDNA with (A) normal or (B) mutant A®T1414 sequence that
were immunolabeled with anti-FLAG to detect the ectopic K5. Similar
disruption of the KIF cytoskeleton was observed in transfected COS cells
expressing the A®T1414 mutant cDNA (data not shown).
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functions provide compelling evidence that an abnormal K5
truncated at K472 can disrupt the K5/K14 cytoskeleton and cause
EBS disease. In addition, there is limited but correlative evidence
supporting a causal role of the K472X abnormal K5 in the patient's
palmar±plantar hyperkeratosis. Recently, an EBS patient was
reported with a KRT5 G®T1429 non-sense mutation, which
predicts a E477X premature translation termination at the last
glutamate residue of the KLLEGE motif (Muller et al, 1999). This
child developed palmar±plantar hyperkeratoses before she began
walking. It should be noted, however, that expression of a
truncated K5 was not demonstrated in this case. We hypothesize
that the palmar±plantar hyperkeratosis in these two patients results
from the inability of truncated K5 molecules to interact properly
with proteins speci®cally expressed in these tissues. This is
consistent with the long held assumption that the divergent tail
(and head) domains of keratins re¯ect specialized functions of the
different keratins in different tissues. Because many genetic and
epigenetic factors could contribute to severe palmar±plantar
hyperkeratosis, it is not unexpected that there are patients with
this phenotype that have keratin mutations other than truncations
of K5 (Kimonis et al, 1994; Shemanko et al, 1998). Our hypothesis,
however, predicts that all EBS patients that express a truncated K5
will have unusually severe palmar±plantar hyperkeratosis. If true,
then the K5 tail domain has important, normal functions in palmar±
plantar tissues that warrant further investigation.
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